Arkolith/Insider Trading/IONS/Form 4

Baroldi Joseph

EVP, Chief Business OfficerIONIS PHARMACEUTICALS INC (IONS) · full profile →Form 4 · filed Apr 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$419K
Net Open-Market Flow
-$419K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 16, 2026Sell(S)6K$74.56$419K47K
Apr 15, 2026Option exercise(M)11K—$052K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 15, 2026Option exercise(M)11K—$048K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000874015-26-000169) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML